|
| November
5, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Lewis H. Bender, Founder & CEO,
Intensity Therapeutics |
| In
this Q&A, Bender discusses the insight
behind Intensity's approach, what sets its
delivery platform apart, lessons he's
learned leading a biotech company through
an IPO and late-stage trials, and changes
needed to get more effective, less toxic
treatments to patients faster. More |
|
|
- Ascentage Pharma: Will Present Data From
Multiple Trials, Including an Oral
Presentation of APG-5918 at ASH 2026 More
- GeneDx and Mirum Pharmaceuticals:
Launch Sponsored Testing Programs to Help
Patients Find Answers Through Comprehensive
Genetic Testing More
|
|
|
|
- Cartesian Therapeutics: Third Quarter 2026
Financial Results and Business Update
More
- Emergent BioSolutions: Receives $22.3
Million Delivery Order Modification to Supply
BioThrax (Anthrax Vaccine Adsorbed) to the
U.S. Department of War More
- November 6, 2026: BioPharmCatalyst Weekly
Watchlist: Key Phase 3 Catalysts Left for the
Quarter More
- Precigen: Third Quarter 2026 Results
Highlighted by Strong Sequential PAPZIMEOS
Revenue Growth and Positive Cash Flow Ahead of
Guidance More
- QIAGEN: Full Q3 2026 Results More
- Quoin Pharmaceuticals: Corporate Update and
Third Quarter 2026 Financial Results More
- United Therapeutics: Buydown of
Ralinepag Royalty More
- United Therapeutics: Third Quarter 2026
Financial Results More
|
|
|
| Turn
unstructured bladder cancer data
into actionable real-world
insights. |
| Download
the case study to learn how. |
|
|
- Big4Bio CEO Weekly Q&A: Lewis H.
Bender, Founder & CEO, Intensity
Therapeutics More
- Biotech & Pharma Updates | November 4,
2026 More
- SciLnq: Therapeutic Antibody
Development Consulting More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- Vanda Drives Straight Into FDA Trouble With
Fast-Paced Nereus Ad More
|
|
|
| Slone
Partners Places Farhad Ghavami as
Chief Executive Officer at
SeqCenter |
|
Learn More
→ |
|
|
- CollectiveMinds: The Boardroom Is
Changing. Is Your Experience Visible?
More
- Fierce Biotech Layoff Tracker 2026:
Ultragenyx Lays Off 20%; Molecular Partners
Trims 44% More
- 1 in 5 Have Had Multiple Biopharma Layoffs,
Poll Finds More
- OPPORTUNITY: Director of Compliance, Remote
More
- OPPORTUNITY: Head of Market
Development & Strategy, California More
- OPPORTUNITY: Senior Vice President,
Regulatory Affairs & Quality Assurance,
Boston More
- Slone Partners: Doing More With Less
- Building the Right Nonprofit Leadership
Team in a Resource-Constrained Environment More
- Slone Partners: Leading Through AI - The New
Playbook for Healthtech Executives More
|
|
 |
Events
|
Note:
Events may be in any Big4Bio region or
virtual |
|
- Scaling Academic Research Programs
Through Strategic Colony Management
Partnerships Nov
11
- 23rd Annual Pantheon Awards
Nov 12
- 2026 LSPA Patient Summit Nov
12
- Patient Pathways (Use code 26B4B10
for 10% off) Nov
17-20
- Pricing & Contracting WEST (Use
code 26B4B10 for 10% off) Dec
7-8
- Trade
and Channel Strategies (Use code 26B4B10
for 10% off) Dec
8-10
- Advancing
Drug Development Forum Dec
10
|
SEE FULL
EVENT SCHEDULE AT THE BIOCALENDAR
|
|
DISCOVER COMPANIES |
|
Big4Bio: Capital Region Life
Science Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
|
|
|
|
|
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Capital
Region, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|